Document is current
Any future updates will be listed below
-
Authors
Veyssiere, Hugo
Dressaire, Margot
Pete, Raphaël
Pinard, Céleste https://orcid.org/0000-0003-2202-7362
Molnar, Ioana
Abrial, Catherine
Ginzac, Angeline
Durando, Xavier
Tekath, Marielle
- License Information
-
More Information
Article History
Received: 14 January 2022
Accepted: 16 May 2023
First Online: 20 July 2023
Declarations
:
: RFID trial has been approved by ethics committee (Ile de France XI) (ID-RCB number: 2021-A00281-40). Patients who agree to participate in this study will provide oral consent for enrolment and the investigator will sign a document demonstrating that the patient has been informed and has agreed to participate.
: Not applicable.
: The authors declare no potential competing interests. The Hologic Company provided the LOCalizer™ RFID tags used in the study.
